2026-04-13T00:13:37Zhttps://recercat.cat/oai/requestoai:recercat.cat:10459.1/695952024-12-05T22:48:45Zcom_2072_3622col_2072_479130
RECERCAT
author
de Hollanda, Ana
author
Lecube Torelló, Albert
author
Rubio, Miguel Ángel
author
Sánchez Peña, Enric
author
Vilarrasa, Núria
author
Gregorio Oliva, José
author
Fernández-Soto, María Luisa
author
Salas-Salvadó, Jordi
author
Ballesteros-Pomar, María D.
author
Ciudin, Andreea
author
Torres, Ferran
author
Vidal, Concepción
author
Morales, María José
author
Valdés, Sergio
author
Pellitero, Silvia
author
Miñambres, Inka
author
Masmiquel, Lluís
author
Goday, Albert
author
Suarez, Lorena
author
Flores, Lilliam
author
Bueno Díez, Marta
author
Caixàs, Assumpta
author
Bretón, Irene
author
Cámara, Rosa
author
Olbeyra, Romina
author
Penso, Rona
author
de la Cruz, María José
author
Simó-Servat, Andreu
author
Pereyra-García, Francisca María
author
López-Mezquita, Elena Teresa
author
Gils, Anna
author
Fidilio, Enzamaria
author
Bandrés, Orosia
author
Martínez, Ángel
author
Abuín, Jose
author
Marques-Pamies, Montserrat
author
Tuneu, Laura
author
Arteaga, Magdalena
author
Castañer, Olga
author
Goñi, Fernando
author
Arrizabalaga, Cristina
author
Botana, Manuel Antonio
author
Calañas, Alfonso
2024-12-05T22:48:45Z
2024-12-05T22:48:45Z
2020-10-02T08:28:57Z2020-10-02T08:28:57Z2020
http://hdl.handle.net/10459.1/69595
Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery
or are unable to sustain this effect long term. Our objective was to delve further into the dynamic
responses of diabetes after bariatric surgery and to evaluate the “time-within-remission range” as a
variable of metabolic control. A descriptive cohort study was done using a computerised multicentre
and multidisciplinary registry. All data were adjusted by propensity score. A total of 1186 subjects
with a follow-up of 4.5 ± 2.5 years were included. Type of surgery, diabetes remission, recurrence
of diabetes, “time-within-remission range” and key predictors of diabetes outcomes were assessed.
All patients (70% women, 51.4 ± 9.2 years old, body mass index (BMI) 46.3 ± 6.9 kg/m2
) underwent
primary bariatric procedures. “Time-within-remission range” were 83.3% (33.3–91.6) after gastric
bypass, 68.7% (7.1–87.5) after sleeve gastrectomy and 90% (83.3–92.8) after malabsorptive techniques
(p < 0.001 for all). Duration of diabetes, baseline HbA1c and insulin treatment were significantly
negatively correlated with the “time-within-remission range”. The association of bariatric techniques
with “time-within-remission range”, using gastric bypass as a reference, were: odds ratio (OR) 3.70
(2.34–5.84), p < 0.001 for malabsorptive techniques and OR 0.55 (0.40–0.75), p < 0.001 for sleeve
gastrectomy. Characteristics of type 2 diabetes powerfully influence the outcomes of bariatric
surgery. The “time-within-remission range” unveils a superiority of gastric bypass compared to
sleeve gastrectomyThis study was supported by the Spanish Society of Endocrinology and Nutrition (SEEN). The RICIBA and RICIBA-DM are property of the Spanish Society of Endocrinology and Nutrition (SEEN). J.S.S. gratefully acknowledges the financial support by ICREA under the ICREA Academia programme.
cc-by (c) de Hollanda, Ana et al., 2020 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/4.0/
Bariatric surgery
Time-within-remission range
Type 2 diabetes
Metabolic control
New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion